Haemonetics Corp. (HAE)
102.48
-0.44
(-0.43%)
USD |
NYSE |
Sep 03, 09:44
Haemonetics Research and Development Expense (Annual) : 58.80M for March 31, 2026
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 58.80M |
| March 31, 2025 | 61.13M |
| March 31, 2024 | 52.23M |
| March 31, 2023 | 49.08M |
| March 31, 2022 | 45.98M |
| March 31, 2021 | 31.69M |
| March 31, 2020 | 30.00M |
| March 31, 2019 | 35.71M |
| March 31, 2018 | 39.23M |
| March 31, 2017 | 37.56M |
| March 31, 2016 | 44.96M |
| March 31, 2015 | 54.19M |
| March 31, 2014 | 50.60M |
| March 31, 2013 | 44.39M |
| March 31, 2012 | 36.80M |
| March 31, 2011 | 32.66M |
| March 31, 2010 | 26.38M |
| March 31, 2009 | 23.86M |
| Date | Value |
|---|---|
| March 31, 2008 | 24.32M |
| March 31, 2007 | 23.88M |
| March 31, 2006 | 22.77M |
| March 31, 2005 | 18.29M |
| March 31, 2004 | 17.40M |
| March 31, 2003 | 19.51M |
| March 31, 2002 | 19.51M |
| March 31, 2001 | 19.04M |
| March 31, 2000 | 14.93M |
| March 31, 1999 | 15.14M |
| March 31, 1998 | 17.93M |
| March 31, 1997 | 18.97M |
| March 31, 1996 | 18.47M |
| March 31, 1995 | 16.73M |
| March 31, 1994 | 15.79M |
| March 31, 1993 | 13.59M |
| March 31, 1992 | 10.48M |
| March 31, 1991 | 8.386M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical, Inc. | 146.94M |
| Abbott Laboratories | 2.889B |
| AngioDynamics, Inc. | 29.45M |
| Alphatec Holdings, Inc. | 76.27M |
| AtriCure, Inc. | 90.17M |